126 related articles for article (PubMed ID: 16711748)
1. WIN55212-2 docking to the CB1 cannabinoid receptor and multiple pathways for conformational induction.
Shim JY; Howlett AC
J Chem Inf Model; 2006; 46(3):1286-300. PubMed ID: 16711748
[TBL] [Abstract][Full Text] [Related]
2. Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.
Shim JY; Welsh WJ; Cartier E; Edwards JL; Howlett AC
J Med Chem; 2002 Mar; 45(7):1447-59. PubMed ID: 11906286
[TBL] [Abstract][Full Text] [Related]
3. Steric trigger as a mechanism for CB1 cannabinoid receptor activation.
Shim JY; Howlett AC
J Chem Inf Comput Sci; 2004; 44(4):1466-76. PubMed ID: 15272855
[TBL] [Abstract][Full Text] [Related]
4. The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes.
Reggio PH; Basu-Dutt S; Barnett-Norris J; Castro MT; Hurst DP; Seltzman HH; Roche MJ; Gilliam AF; Thomas BF; Stevenson LA; Pertwee RG; Abood ME
J Med Chem; 1998 Dec; 41(26):5177-87. PubMed ID: 9857088
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
6. Ligand-specific homology modeling of human cannabinoid (CB1) receptor.
Ai R; Chang CE
J Mol Graph Model; 2012 Sep; 38():155-64. PubMed ID: 23079645
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
Shim JY; Collantes ER; Welsh WJ; Subramaniam B; Howlett AC; Eissenstat MA; Ward SJ
J Med Chem; 1998 Nov; 41(23):4521-32. PubMed ID: 9804691
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
Dhawan J; Deng H; Gatley SJ; Makriyannis A; Akinfeleye T; Bruneus M; Dimaio AA; Gifford AN
Synapse; 2006 Aug; 60(2):93-101. PubMed ID: 16715483
[TBL] [Abstract][Full Text] [Related]
9. High-resolution NMR and computer modeling studies of the cannabimimetic aminoalkylindole prototype WIN-55212-2.
Xie XQ; Han XW; Chen JZ; Eissenstat M; Makriyannis A
J Med Chem; 1999 Oct; 42(20):4021-7. PubMed ID: 10514272
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Ashton JC; Wright JL; McPartland JM; Tyndall JD
Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
[TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist.
Zhang Q; Ma P; Iszard M; Cole RB; Wang W; Wang G
Drug Metab Dispos; 2002 Oct; 30(10):1077-86. PubMed ID: 12228183
[TBL] [Abstract][Full Text] [Related]
12. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
Khajehali E; Malone DT; Glass M; Sexton PM; Christopoulos A; Leach K
Mol Pharmacol; 2015 Aug; 88(2):368-79. PubMed ID: 26044547
[TBL] [Abstract][Full Text] [Related]
13. Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling.
Georgieva T; Devanathan S; Stropova D; Park CK; Salamon Z; Tollin G; Hruby VJ; Roeske WR; Yamamura HI; Varga E
Eur J Pharmacol; 2008 Feb; 581(1-2):19-29. PubMed ID: 18162180
[TBL] [Abstract][Full Text] [Related]
14. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
Shim JY; Welsh WJ; Howlett AC
Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids depress excitatory neurotransmission between the subthalamic nucleus and the globus pallidus.
Freiman I; Szabo B
Neuroscience; 2005; 133(1):305-13. PubMed ID: 15893652
[TBL] [Abstract][Full Text] [Related]
16. Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy.
Falenski KW; Blair RE; Sim-Selley LJ; Martin BR; DeLorenzo RJ
Neuroscience; 2007 May; 146(3):1232-44. PubMed ID: 17433556
[TBL] [Abstract][Full Text] [Related]
17. (-)-7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor.
Picone RP; Khanolkar AD; Xu W; Ayotte LA; Thakur GA; Hurst DP; Abood ME; Reggio PH; Fournier DJ; Makriyannis A
Mol Pharmacol; 2005 Dec; 68(6):1623-35. PubMed ID: 16157695
[TBL] [Abstract][Full Text] [Related]
18. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
19. Mutation studies of Ser7.39 and Ser2.60 in the human CB1 cannabinoid receptor: evidence for a serine-induced bend in CB1 transmembrane helix 7.
Kapur A; Hurst DP; Fleischer D; Whitnell R; Thakur GA; Makriyannis A; Reggio PH; Abood ME
Mol Pharmacol; 2007 Jun; 71(6):1512-24. PubMed ID: 17384224
[TBL] [Abstract][Full Text] [Related]
20. Interaction of brain cannabinoid receptors with guanine nucleotide binding protein: a radioligand binding study.
Petitet F; Jeantaud B; Capet M; Doble A
Biochem Pharmacol; 1997 Dec; 54(11):1267-70. PubMed ID: 9416978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
